zynex shares slid 28 to 1045 after chief executive thomas sandgaard said he will not pursue the public offering of two million shares of the companys common stock announced on wednesday the medical devices manufacturer said mr sandgaards decision was due to an assessment that current market conditions arent conducive to the offering on terms that would be in his best interest zynex said it continues to intend to pursue its previously announced private offering to qualified institutional buyers of 50 million aggregate principal amount of convertible senior notes due in 2026